April 16 /PRNewswire/ -- The world industrial and academic neuroscience communities will convene in Princeton, NJ on July 23-24, 2001, to speak, attend, and present posters at the ``4th International Neurodegeneration in Alzheimer's Disease, Parkinson's Disease and Related Disorders'' conference, announces Strategic Research Institute.
Featured among the excellent papers to be presented are ``Alzheimer's B-Secretase Protein BACE 1: A target for Treatment of Alzheimer's Disease'' to be presented by Dr Martin Citron of Amgen, Inc., ``The evolution of Neural and Stem Cell Therapies for Parkinson's Disease'', to be presented by Dr. Ole Isacson of Harvard Medical School and McKlean Hospital, ``Development of Radioligands for in vivo Imaging of Brain Amyloid'', to be presented by Dr. Virginia M.-Y. Lee of the University of Pennsylvania School Of Medicine, and Galantamine: Results from the Clinical Development Program, to be presented by Sean Lilienfeld of Janssen Research Foundation.
The broad-based meeting is divided into six sections, namely, Parkinson's Disease, Novel Therapeutic Targets in Neurodegeneration, Pathophysiology of Alzheimer's Disease, Amyloid Processing, Novel Therapeutic Targets for Neurodegeneration, and Therapeutic Advances.
Other presenting companies and academic institutions are Aventis Pharmaceuticals, NeoTherapeutics, Pfizer, New York Medical Center, The R.W. Johnson Pharmaceutical Research Institute, Binzou People's Hospital -- China, Brigham and Women's Hospital, MitoKor, Neurochem, Johns Hopkins University, Eli Lilly & Company, Exelexis, Guilford Pharmaceuticals, and ACADIA Pharmaceuticals.
To request the agenda, please contact Bebe Anderson at banderson@srinstitute.com or 212-967-0095, ext. 255, or Sumeet Hora at shora@srinstitute.com or 212-967-0095, ext. 261. Please include your affiliation, mailing address, and fax number... |
